Top View
- From Bench to Bedside . . . but When? Charis Eng1
- NCCN Guidelines®) Genetic/Familial High-Risk Assessment: Colorectal
- Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
- A Brother and Sister with Breast Cancer, BRCA2 Mutations and Bilateral Supernumerary Nipples
- Genetic Testing for Inherited Mutations Or Susceptibility to Cancer Or Other Conditions Med207.110 ______Coverage
- Cancer Genes & Cancer Genetics
- Predicting and Affecting Response to Cancer Therapy Based on Pathway-Level Biomarkers
- Clinician Management Resource for BRCA2
- Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence
- The BRCA2 Activation Domain Associates with and Is Phosphorylated by a Cellular Protein Kinase
- Double Trouble: Concomitant RB1 and BRCA2 Depletion Evokes Aggressive Phenotypes
- Ion Ampliseq BRCA1 and BRCA2 Panel a Community Panel Designed with Input from Leading Researchers
- High-Grade Serous Ovarian Cancer Arises from Fallopian Tube in a Mouse Model
- Determination of Molecular Markers for BRCA1 and BRCA2 Heterozygosity Using Gene Expression Profiling
- Significance of BRCA2 and RB1 Co-Loss in Aggressive Prostate Cancer Progression
- Hereditary Cancer Panel Descriptions
- BRCA1 and BRCA2 Genes Mutations Among High Risk Breast Cancer
- Aurora Kinase B Inhibition: a Potential Therapeutic Strategy for Cancer
- Review BRCA1 and BRCA2 Proteins: Roles in Health and Disease
- The Role of PALB2 in BRCA1/2-Mediated DNA Repair and Tumor Suppression DISSERTATION Presented in Partial Fulfillment of the Requ
- (HBOC) the Risk for Cancer Associated with BRCA1 and BRCA2 Gene
- Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer Xia Wang1, Roope A
- Mouse Models of BRCA1 and BRCA2 Deficiency
- Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
- Oncological Implications of RET Gene Mutations in Hirschsprung's Disease
- AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51
- Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer
- The BRCA2 Is a Histone Acetyltransferase
- Breast Cancer and Neurofibromatosis Type 1
- Novel Loss‑Of‑Function Mutation in BRCA2 Gene Identified in a Chinese Female with a Family History of Ovarian Cancer: a Case Report
- CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather Than Checkmate
- Mutated P53 in HGSC—From a Common Mutation to a Target for Therapy
- Stathmin 1, a Marker of PI3K Pathway Activation and Regulator of Microtubule Dynamics, Is Expressed in Early Pelvic Serous Carcinomas
- Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: a Multicenter Study
- Targeting RB1 Loss in Cancers
- Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast Cancer
- It's Totally Tubular• • • •Riding the New Wave of Ovarian Cancer Research
- Targeting Wnt Signaling to Overcome PARP Inhibitor Resistance
- BRCA1 and BRCA2 For
- GENETICS of COLORECT AL NEOPLASIA Somatic Mutations Within an Individual Cell Give Rige to Colorectal Cancer Provides an Ideal Model to Study Tu- Transformation
- Expression and Mutations of BRCA in Breast Cancer and Ovarian Cancer: Evidence from Bioinformatics Analyses
- Attenuated Familial Adenomatous Polyposis Manifests As Autosomal Dominant Late-Onset Colorectal Cancer
- Hereditary Breast and Ovarian Cancer Syndrome
- Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma Vasiliki Panou, Meghana Gadiraju, Arthur Wolin, Caroline M
- BRCA2 and P53 Mutations in Primary Breast Cancer in Relation to Genetic Instability1
- The CHEK2 Gene and Inherited Breast Cancer Susceptibility
- Product Description SALSA® MLPA® Probemix P045-D1 BRCA2/CHEK2 to Be Used with the MLPA General Protocol
- BRCA1 and BRCA2 Analysis. Because Knowledge Is a Powerful Tool
- New Insights Into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response
- NRF2, a Transcription Factor for Stress Response and Beyond
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
- Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variants of Unknown Clinical Significance
- PI3K/AKT/Mtor Signaling Pathway in Breast Cancer: from Molecular Landscape to Clinical Aspects
- Genetic Testing for Hereditary Cancer Susceptibility
- Characterization of a Novel DNA Binding Domain in the N-Terminus of BRCA2 and Evaluation of BRCA2 Variants Identified in Breast
- The Tardigrade Damage Suppressor Protein Promotes Tran- Scription Factor Activation and Expression of DNA Repair Genes in Human
- Targeting Transcription Factors for Cancer Treatment
- Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women
- Brcal /Brca2, Brcal /P53, and Brca2/P53 Nullizygous Embryos
- Access Array BRCA1 / BRCA2 / TP53 Target-Specific Panel Build the Highest Quality Amplicon Libraries with Qualified Assays
- The BRCA2 Gene Product Functionally Interacts with P53 and RAD51
- WNT Inhibition Creates a BRCA-‐Like State in Wnt-‐ Addicted Cancer
- Junb Potentiates Function of BRCA1 Activation Domain 1 (AD1) Through a Coiled-Coil-Mediated Interaction
- A Transcription-Based Mechanism for Oncogenic β-Catenin-Induced Lethality in BRCA1/2-Deficient Cells
- Morphologic Patterns Associated with BRCA1 and BRCA2 Genotype in Ovarian Carcinoma
- TUMOR-SUPPRESSOR TUMOR SUPPRESSOR GENES Molecular Oncology 2012
- Genetic Counseling, Polymorphisms and Breast Cancer Kleber Santiago Freitas E Silva*